Treatment of Patients with ALK-positive Non-small Cell Lung Cancer and Brain Metastases
Treatment of Patients with ALK-positive Non-small Cell Lung Cancer and Brain Metastases
About this item
Full title
Author / Creator
Lv, Jialin , Zhang, Quan , Qin, Na , Yang, Xinjie , Zhang, Xinyong , Wu, Yuhua , Li, Xi , Zhang, Hui , Wang, Jinghui and Zhang, Shucai
Publisher
China: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Journal title
Language
Chinese
Formats
Publication information
Publisher
China: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Subjects
More information
Scope and Contents
Contents
Anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) is an important subtype of lung cancer. The standard modality of ALK-positive NSCLC with brain metastases remains uncertain.
We collected data on clinical characteristics and treatment of patients with ALK-positive NSCLC and brain metastases between March 2013 and March...
Alternative Titles
Full title
Treatment of Patients with ALK-positive Non-small Cell Lung Cancer and Brain Metastases
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b4bdaa9b389546d4acf11dd2a6bc51a5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b4bdaa9b389546d4acf11dd2a6bc51a5
Other Identifiers
ISSN
1009-3419
E-ISSN
1999-6187
DOI
10.3779/j.issn.1009-3419.2016.08.06
